Cargando…

FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway

FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Keigo, Nogami, Ayako, Ishida, Shinya, Akiyama, Hiroki, Chen, Cheng, Umezawa, Yoshihiro, Miura, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823622/
https://www.ncbi.nlm.nih.gov/pubmed/29507660
http://dx.doi.org/10.18632/oncotarget.22926
_version_ 1783301910305964032
author Okada, Keigo
Nogami, Ayako
Ishida, Shinya
Akiyama, Hiroki
Chen, Cheng
Umezawa, Yoshihiro
Miura, Osamu
author_facet Okada, Keigo
Nogami, Ayako
Ishida, Shinya
Akiyama, Hiroki
Chen, Cheng
Umezawa, Yoshihiro
Miura, Osamu
author_sort Okada, Keigo
collection PubMed
description FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) but not by FLT3 mutated in the tyrosine kinase domain (32D/TKD). Here, we report the involvement of Pim kinases expressed through STAT5 activation in acquisition of this resistance. The specific pan-Pim kinase inhibitor AZD1208 as well as PIM447 in combination with the PI3K inhibitor GDC-0941 or the Akt inhibitor MK-2206 cooperatively downregulated the mTORC1/4EBP1 pathway, formation of the eIF4E/eIF4G complex, and Mcl-1 expression leading to activation of Bak and Bax to induce caspase-dependent apoptosis synergistically in these cells. These cooperative effects were enhanced or inhibited by knock down of mTOR or expression of its activated mutant, respectively. Overexpression of Mcl-1 conferred the resistance on 32D/ITD cells to combined inhibition of the PI3K/Akt pathway and Pim kinases, while the Mcl-1-specific BH3 mimetic A-1210477 conquered the resistance of MV4-11 cells to GDC-0941. Furthermore, overexpression of Pim-1 in 32D/TKD enhanced the mTORC1/Mcl-1 pathway and partially protected it from the PI3K/Akt inhibitors or the FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt inhibitors. Finally, AZD1208 and GDC-0941 cooperatively inhibited the mTORC1/Mcl-1 pathway and reduced viable cell numbers of primary AML cells from some FLT3-ITD positive cases. Thus, Pim kinases may protect the mTORC1/4EBP1/Mcl-1 pathway to confer the resistance to the PI3K/Akt inhibitors on FLT3-ITD cells and represent promising therapeutic targets.
format Online
Article
Text
id pubmed-5823622
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-58236222018-03-05 FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway Okada, Keigo Nogami, Ayako Ishida, Shinya Akiyama, Hiroki Chen, Cheng Umezawa, Yoshihiro Miura, Osamu Oncotarget Research Paper FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML) associated with poor prognosis. We previously reported that activation of STAT5 confers resistance to PI3K/Akt inhibitors on the FLT3-ITD-positive AML cell line MV4-11 and 32D cells driven by FLT3-ITD (32D/ITD) but not by FLT3 mutated in the tyrosine kinase domain (32D/TKD). Here, we report the involvement of Pim kinases expressed through STAT5 activation in acquisition of this resistance. The specific pan-Pim kinase inhibitor AZD1208 as well as PIM447 in combination with the PI3K inhibitor GDC-0941 or the Akt inhibitor MK-2206 cooperatively downregulated the mTORC1/4EBP1 pathway, formation of the eIF4E/eIF4G complex, and Mcl-1 expression leading to activation of Bak and Bax to induce caspase-dependent apoptosis synergistically in these cells. These cooperative effects were enhanced or inhibited by knock down of mTOR or expression of its activated mutant, respectively. Overexpression of Mcl-1 conferred the resistance on 32D/ITD cells to combined inhibition of the PI3K/Akt pathway and Pim kinases, while the Mcl-1-specific BH3 mimetic A-1210477 conquered the resistance of MV4-11 cells to GDC-0941. Furthermore, overexpression of Pim-1 in 32D/TKD enhanced the mTORC1/Mcl-1 pathway and partially protected it from the PI3K/Akt inhibitors or the FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt inhibitors. Finally, AZD1208 and GDC-0941 cooperatively inhibited the mTORC1/Mcl-1 pathway and reduced viable cell numbers of primary AML cells from some FLT3-ITD positive cases. Thus, Pim kinases may protect the mTORC1/4EBP1/Mcl-1 pathway to confer the resistance to the PI3K/Akt inhibitors on FLT3-ITD cells and represent promising therapeutic targets. Impact Journals LLC 2017-12-04 /pmc/articles/PMC5823622/ /pubmed/29507660 http://dx.doi.org/10.18632/oncotarget.22926 Text en Copyright: © 2018 Okada et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Okada, Keigo
Nogami, Ayako
Ishida, Shinya
Akiyama, Hiroki
Chen, Cheng
Umezawa, Yoshihiro
Miura, Osamu
FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title_full FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title_fullStr FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title_full_unstemmed FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title_short FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway
title_sort flt3-itd induces expression of pim kinases through stat5 to confer resistance to the pi3k/akt pathway inhibitors on leukemic cells by enhancing the mtorc1/mcl-1 pathway
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823622/
https://www.ncbi.nlm.nih.gov/pubmed/29507660
http://dx.doi.org/10.18632/oncotarget.22926
work_keys_str_mv AT okadakeigo flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT nogamiayako flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT ishidashinya flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT akiyamahiroki flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT chencheng flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT umezawayoshihiro flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway
AT miuraosamu flt3itdinducesexpressionofpimkinasesthroughstat5toconferresistancetothepi3kaktpathwayinhibitorsonleukemiccellsbyenhancingthemtorc1mcl1pathway